Cancer Treatment Reviews
Volume 30, Issue 5 , Pages 473-477 , August 2004

Post-operative chemotherapy improves disease-free survival, but not overall survival in people with oesophageal squamous cell carcinoma: Abstracted from: Ando N, Iizuka T, Ide H et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study – JCOG9204. Journal of Clinical Oncology 2003;21:4592–6.

References 

  1. Jemal A, Tiwari RC, Murray T, et al.  Cancer statistics. CA Cancer J. Clin. 2004;54:8–29
  2. Kelsen DP, Ginsberg R, Pajak TF, et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N. Engl. J. Med. 1998;339:1979–1984
  3. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727–33
  4. Malthaner R, Fenlon D. Preoperative chemotherapy for resectable thoracic esophageal cancer. Cochrane Database Syst. Rev. 2001;(1):CD001556
  5. Urschel JD, Vasan H, Blewett CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer. Am. J. Surg. 2002;183:274–279
  6. Ando N, Iizuka T, Ide H, et al.  Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study–JCOG9204. J. Clin. Oncol. 2003;21:4592–4596
  7. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am. J. Surg. 2003;185:538–543
  8. Macdonald JS, Smalley SR, Benedetti J, et al.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med. 2001;345:725–730
  9. Daly JM, Karnell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer. 1996;78:1820–1828
  10. Allum W, Cunningham D, Weeden S. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial (the MAGIC trial, ISRCTN 93793971). Proc. Am. Soc. Clin. Oncol. 2003;22:249; (Abstract 998)
  11. Ilson DH, Saltz L, Enzinger P, et al.  Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J. Clin. Oncol. 1999;17:3270–3275

☆ Sources of funding: This study was supported by the Ministry of Health, Labor and Welfare of Japan and the Second Term Comprehensive 10-Year Strategy for Cancer Control.

☆☆ For Correspondence: Nobutoshi Ando, Department of Surgery, Tokyo Dental College, Ichikawa General Hospital, Sugano, Ichikawashi, Chiba, Japan. E-mail: nando@tdc.ac.jp.

★ Abstract provided by Bazian Ltd., London.

PII: S0305-7372(04)00100-8

doi: 10.1016/j.ctrv.2004.05.007

Cancer Treatment Reviews
Volume 30, Issue 5 , Pages 473-477 , August 2004

Article Tools